[
  {
    "RxNorm (RxCUI)": 1100072,
    "Ingredient Name": "abiraterone",
    "Form": "oral tablet",
    "Supplemental information": "Women who are pregnantor may be pregnant shouldnot handle without protec-tion (e.g.| gloves); FDAPregnancy Category XConjugated monoclonalantibody; FDA Pregnancy",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4e338e89-3cf2-48eb-b6e2-a06c608c6513",
    "DrugBank": "http://www.drugbank.ca/drugs/DB05812"
  },
  {
    "RxNorm (RxCUI)": 1371041,
    "Ingredient Name": "ado-trastuzumab emtansine",
    "Form": "injectable",
    "Supplemental information": "Conjugated monoclonal antibody; FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e",
    "DrugBank": "http://www.drugbank.ca/drugs/DB05773"
  },
  {
    "RxNorm (RxCUI)": 1430438,
    "Ingredient Name": "afatinib",
    "Form": "oral tablet",
    "Supplemental information": "Special warnings on while taking and 2 weekspost-treatment; FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fd638e5e-8032-e7ca-0179-95e96ab5d387",
    "DrugBank": "http://www.drugbank.ca/drugs/DB08916"
  },
  {
    "RxNorm (RxCUI)": 5296,
    "Ingredient Name": "altretamine",
    "Form": "oral tablet",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=altretamine",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00488"
  },
  {
    "RxNorm (RxCUI)": 739,
    "Ingredient Name": "amsacrine",
    "Form": "injectable",
    "Supplemental information": "IARC Group 2B%u2020",
    "Personal Protective Equipment": "",
    "DailyMed": "",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00276"
  },
  {
    "RxNorm (RxCUI)": 84857,
    "Ingredient Name": "anastrozole",
    "Form": "oral tablet",
    "Supplemental information": "FDA Pregnancy Category X",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=anastrozole",
    "DrugBank": "http://www.drugbank.ca/drugs/DB01217"
  },
  {
    "RxNorm (RxCUI)": 18330,
    "Ingredient Name": "arsenic trioxide",
    "Form": "injectable",
    "Supplemental information": "IARC Group 1 carcinogen; NTP**; FDA Pregnancy\nCategory D",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dec51fab-3784-deb7-752f-2d4d5692a20f",
    "DrugBank": "http://www.drugbank.ca/drugs/DB01169"
  },
  {
    "RxNorm (RxCUI)": 1242999,
    "Ingredient Name": "axitinib",
    "Form": "oral tablet",
    "Supplemental information": "Teratogenic| embryotoxic\nand fetotoxic in mice at exposures lower than human exposures; FDA Pregnancy category D",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=axitinib",
    "DrugBank": "http://www.drugbank.ca/drugs/DB06626"
  },
  {
    "RxNorm (RxCUI)": 1251,
    "Ingredient Name": "azacitidine",
    "Form": "injectable",
    "Supplemental information": "IARC Group 2A carcinogen; NTP***; FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=azacitidine",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00928"
  },
  {
    "RxNorm (RxCUI)": 221050,
    "Ingredient Name": "Bacillus Calmette-Guerin (BCG)",
    "Form": "injectable & topical",
    "Supplemental information": "requirements%u2021; FDA Pregnancy Category C",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=bcg",
    "DrugBank": ""
  },
  {
    "RxNorm (RxCUI)": 1543543,
    "Ingredient Name": "belinostat",
    "Form": "injectable",
    "Supplemental information": "May cause teratogenicity and/or embryo-fetal lethality because it is a genotoxic drug and targets actively dividing cells; FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=84b2e16e-f0d1-4757-8da8-79dfa83aab79",
    "DrugBank": "http://www.drugbank.ca/drugs/DB05015"
  },
  {
    "RxNorm (RxCUI)": 134547,
    "Ingredient Name": "bendamustine",
    "Form": "injectable",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=39d53698-57fa-7c99-fc5b-f52a55684826",
    "DrugBank": "http://www.drugbank.ca/drugs/DB06769"
  },
  {
    "RxNorm (RxCUI)": 233272,
    "Ingredient Name": "bexarotene",
    "Form": "oral tablet & topical",
    "Supplemental information": "FDA Pregnancy Category X",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=bexarotene",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00307"
  },
  {
    "RxNorm (RxCUI)": 83008,
    "Ingredient Name": "bicalutamide",
    "Form": "oral tablet",
    "Supplemental information": "FDA Pregnancy Category X",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=bicalutamide",
    "DrugBank": "http://www.drugbank.ca/drugs/DB01128"
  },
  {
    "RxNorm (RxCUI)": 1622,
    "Ingredient Name": "bleomycin",
    "Form": "injectable",
    "Supplemental information": "IARC Group 2B; FDA Preg-",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=bleomycin",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00290"
  },
  {
    "RxNorm (RxCUI)": 358258,
    "Ingredient Name": "bortezomib",
    "Form": "injectable",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1521d321-e724-4ffc-adad-34bf4f44fac7",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00188"
  },
  {
    "RxNorm (RxCUI)": 1307619,
    "Ingredient Name": "bosutinib",
    "Form": "oral tablet",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=bosutinib",
    "DrugBank": "http://www.drugbank.ca/drugs/DB06616"
  },
  {
    "RxNorm (RxCUI)": 1147320,
    "Ingredient Name": "brentuximab vedotin",
    "Form": "injectable",
    "Supplemental information": "Conjugated monoclonal antibody; FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3904f8dd-1aef-3490-e48f-bd55f32ed67f",
    "DrugBank": "http://www.drugbank.ca/drugs/DB08870"
  },
  {
    "RxNorm (RxCUI)": 1828,
    "Ingredient Name": "busulfan",
    "Form": "oral tablet & injectable",
    "Supplemental information": "IARC Group 1 carcinogen; FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=busulfan",
    "DrugBank": "http://www.drugbank.ca/drugs/DB01008"
  },
  {
    "RxNorm (RxCUI)": 996051,
    "Ingredient Name": "cabazitaxel",
    "Form": "injectable",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=de3d9c26-572b-4ea4-9b2d-dd58a2b3e8fa",
    "DrugBank": "http://www.drugbank.ca/drugs/DB06772"
  },
  {
    "RxNorm (RxCUI)": 1363268,
    "Ingredient Name": "cabozantinib",
    "Form": "oral tablet",
    "Supplemental information": "Embryolethal in rats at exposures below the recommended human dose; FDA Pregnancy category D",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1a0c3bea-c87b-4d25-bb44-5f0174da6b34",
    "DrugBank": "http://www.drugbank.ca/drugs/DB08875"
  },
  {
    "RxNorm (RxCUI)": 194000,
    "Ingredient Name": "capecitabine",
    "Form": "oral tablet",
    "Supplemental information": "Metabolized to 5-fluo-rouracil; FDA Pregnancy",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=capecitabine",
    "DrugBank": "http://www.drugbank.ca/drugs/DB01101"
  },
  {
    "RxNorm (RxCUI)": 40048,
    "Ingredient Name": "carboplatin",
    "Form": "injectable",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=carboplatin",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00958"
  },
  {
    "RxNorm (RxCUI)": 1302966,
    "Ingredient Name": "carfilzomib",
    "Form": "injectable",
    "Supplemental information": "Special warnings on contraception while taking and 2 weeks post-treatment; FDA Pregnancy category D",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ea66eb30-e665-4693-99a1-a9d3b4bbe2d6",
    "DrugBank": "http://www.drugbank.ca/drugs/DB08889"
  },
  {
    "RxNorm (RxCUI)": 2105,
    "Ingredient Name": "carmustine",
    "Form": "injectable",
    "Supplemental information": "IARC Group 2A carcinogen; NTP***; FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=carmustine",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00262"
  },
  {
    "RxNorm (RxCUI)": 2346,
    "Ingredient Name": "chlorambucil",
    "Form": "oral tablet",
    "Supplemental information": "IARC Group 1 carcinogen; NTP**; FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=chlorambucil",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00291"
  },
  {
    "RxNorm (RxCUI)": 2555,
    "Ingredient Name": "cisplatin",
    "Form": "injectable",
    "Supplemental information": "IARC Group 2A carcinogen; NTP***; FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=chlorambucil",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00515"
  },
  {
    "RxNorm (RxCUI)": 44157,
    "Ingredient Name": "cladribine",
    "Form": "injectable",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=cladribine",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00242"
  },
  {
    "RxNorm (RxCUI)": 44151,
    "Ingredient Name": "clofarabine",
    "Form": "injectable",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=clofarabine",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00631"
  },
  {
    "RxNorm (RxCUI)": 1148495,
    "Ingredient Name": "crizotinib",
    "Form": "oral tablet",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2a51b0de-47d6-455e-a94c-d2c737b04ff7",
    "DrugBank": "http://www.drugbank.ca/drugs/DB08865"
  },
  {
    "RxNorm (RxCUI)": 3002,
    "Ingredient Name": "cyclophosphamide",
    "Form": "oral tablet & injectable",
    "Supplemental information": "IARC Group 1 carcinogen; NTP**; FDA PregnancyCategory D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=cyclophosphamide",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00531"
  },
  {
    "RxNorm (RxCUI)": 3041,
    "Ingredient Name": "cytarabine",
    "Form": "injectable",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=cytarabine",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00987"
  },
  {
    "RxNorm (RxCUI)": 1424911,
    "Ingredient Name": "dabrafenib",
    "Form": "oral tablet",
    "Supplemental information": "Special warnings oncontraception for femaleswhile taking and 2 weekspost-treatment; FDA Preg-nancy Category DNTP***; FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=803beaaa-33f9-48cc-9a95-c2e887e095b4",
    "DrugBank": "http://www.drugbank.ca/drugs/DB08912"
  },
  {
    "RxNorm (RxCUI)": 3098,
    "Ingredient Name": "dacarbazine",
    "Form": "injectable",
    "Supplemental information": "NTP***; FDA Pregnancy Category C",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=dacarbazine",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00851"
  },
  {
    "RxNorm (RxCUI)": 3100,
    "Ingredient Name": "dactinomycin",
    "Form": "injectable",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9914e793-a49c-eb00-1ab7-f606c786fe25",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00970"
  },
  {
    "RxNorm (RxCUI)": 475342,
    "Ingredient Name": "dasatinib",
    "Form": "oral tablet",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=dasatinib",
    "DrugBank": "http://www.drugbank.ca/drugs/DB01254"
  },
  {
    "RxNorm (RxCUI)": 3109,
    "Ingredient Name": "daunorubicin",
    "Form": "injectable",
    "Supplemental information": "IARC Group 2B| AKA dau-nomycin; FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=daunorubicin",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00694"
  },
  {
    "RxNorm (RxCUI)": 15657,
    "Ingredient Name": "decitabine",
    "Form": "injectable",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=decitabine",
    "DrugBank": "http://www.drugbank.ca/drugs/DB01262"
  },
  {
    "RxNorm (RxCUI)": 475230,
    "Ingredient Name": "degarelix",
    "Form": "injectable",
    "Supplemental information": "FDA Pregnancy Category X",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ab11dd8a-0fd9-4013-89ab-e114557c7e4b",
    "DrugBank": "http://www.drugbank.ca/drugs/DB06699"
  },
  {
    "RxNorm (RxCUI)": 72962,
    "Ingredient Name": "docetaxel",
    "Form": "injectable",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=docetaxel",
    "DrugBank": "http://www.drugbank.ca/drugs/DB01248"
  },
  {
    "RxNorm (RxCUI)": 3639,
    "Ingredient Name": "doxorubicin",
    "Form": "injectable",
    "Supplemental information": "IARC Group 2A carcinogen; NTP***; FDA PregnancyCategory D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=doxorubicin",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00997"
  },
  {
    "RxNorm (RxCUI)": 1307298,
    "Ingredient Name": "enzalutamide",
    "Form": "oral capsule",
    "Supplemental information": "Embryo-fetal toxicity inmice at exposures that were lower than in patients\treceiving the recommend-\ted dose; FDA Pregnancy\tCategory X",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b129fdc9-1d8e-425c-a5a9-8a2ed36dfbdf",
    "DrugBank": "http://www.drugbank.ca/drugs/DB08899"
  },
  {
    "RxNorm (RxCUI)": 3995,
    "Ingredient Name": "epirubicin",
    "Form": "injectable",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=epirubicin",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00445"
  },
  {
    "RxNorm (RxCUI)": 1045453,
    "Ingredient Name": "eribulin",
    "Form": "injectable",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=31ce4750-ded5-4a0b-95e9-f229fa6bc822",
    "DrugBank": "http://www.drugbank.ca/drugs/DB08871"
  },
  {
    "RxNorm (RxCUI)": 337525,
    "Ingredient Name": "erlotinib",
    "Form": "oral tablet",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=erlotinib",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00530"
  },
  {
    "RxNorm (RxCUI)": 4089,
    "Ingredient Name": "estramustine",
    "Form": "oral capsule",
    "Supplemental information": "FDA Pregnancy Category X",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a9b01bc6-95ac-46f9-befa-d845a74d53c1",
    "DrugBank": "http://www.drugbank.ca/drugs/DB01196"
  },
  {
    "RxNorm (RxCUI)": 4179,
    "Ingredient Name": "etoposide",
    "Form": "oral capsule",
    "Supplemental information": "IARC Group 1 carcinogen; FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=etoposide",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00773"
  },
  {
    "RxNorm (RxCUI)": 141704,
    "Ingredient Name": "everolimus",
    "Form": "oral tablet",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=everolimus",
    "DrugBank": "http://www.drugbank.ca/drugs/DB01590"
  },
  {
    "RxNorm (RxCUI)": 258494,
    "Ingredient Name": "exemestane",
    "Form": "oral tablet",
    "Supplemental information": "FDA Pregnancy Category X",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=exemestane",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00990"
  },
  {
    "RxNorm (RxCUI)": 4488,
    "Ingredient Name": "floxuridine",
    "Form": "injectable",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c8edabc1-67cd-421b-a147-7c1f19f05b8e",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00322"
  },
  {
    "RxNorm (RxCUI)": 24698,
    "Ingredient Name": "fludarabine",
    "Form": "oral tablet & injectable",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=fludarabine",
    "DrugBank": "http://www.drugbank.ca/drugs/DB01073"
  },
  {
    "RxNorm (RxCUI)": 4492,
    "Ingredient Name": "fluorouracil",
    "Form": "oral capsule & injectable & topical",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=fluorouracil",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00544"
  },
  {
    "RxNorm (RxCUI)": 4508,
    "Ingredient Name": "flutamide",
    "Form": "oral capsule",
    "Supplemental information": "Indicated only for men;FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=flutamide",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00499"
  },
  {
    "RxNorm (RxCUI)": 282357,
    "Ingredient Name": "fulvestrant",
    "Form": "injectable",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=83d7a440-e904-4e36-afb5-cb02b1c919f7",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00947"
  },
  {
    "RxNorm (RxCUI)": 12574,
    "Ingredient Name": "gemcitabine",
    "Form": "injectable",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=gemcitabine",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00441"
  },
  {
    "RxNorm (RxCUI)": 1294580,
    "Ingredient Name": "gemtuzumab ozogamicin",
    "Form": "injectable",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=32fd2bb2-1cfa-4250-feb8-d7956c794e05",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00056"
  },
  {
    "RxNorm (RxCUI)": 50610,
    "Ingredient Name": "goserelin",
    "Form": "implant product",
    "Supplemental information": "FDA Pregnancy Category X",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=goserelin",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00014"
  },
  {
    "RxNorm (RxCUI)": 50975,
    "Ingredient Name": "histrelin",
    "Form": "implant product",
    "Supplemental information": "Can cause fetal harm when administered to a pregnant patient| with the possibility of spontaneous abortion; FDA Pregnancy Category X",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=histrelin",
    "DrugBank": "http://www.drugbank.ca/drugs/DB06788"
  },
  {
    "RxNorm (RxCUI)": 5552,
    "Ingredient Name": "hydroxyurea",
    "Form": "oral capsule",
    "Supplemental information": "Special warning on han-dling bottles and capsules;FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=hydroxyurea",
    "DrugBank": "http://www.drugbank.ca/drugs/DB01005"
  },
  {
    "RxNorm (RxCUI)": 5650,
    "Ingredient Name": "idarubicin",
    "Form": "oral capsule & injectable",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=idarubicin",
    "DrugBank": "http://www.drugbank.ca/drugs/DB01177"
  },
  {
    "RxNorm (RxCUI)": 5657,
    "Ingredient Name": "ifosfamide",
    "Form": "injectable",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=ifosfamide",
    "DrugBank": "http://www.drugbank.ca/drugs/DB01181"
  },
  {
    "RxNorm (RxCUI)": 282388,
    "Ingredient Name": "imatinib",
    "Form": "oral capsule",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=imatinib",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00619"
  },
  {
    "RxNorm (RxCUI)": 51499,
    "Ingredient Name": "irinotecan",
    "Form": "injectable",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=irinotecan",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00762"
  },
  {
    "RxNorm (RxCUI)": 1723735,
    "Ingredient Name": "ixazomib",
    "Form": "oral capsule",
    "Supplemental information": "Male and female patientsof childbearing potential must use effective contraceptive measures during and for 3 months following treatment",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fcef9088-ebab-4bd8-933f-c35f9c8bd50b",
    "DrugBank": "http://www.drugbank.ca/drugs/DB09570"
  },
  {
    "RxNorm (RxCUI)": 337523,
    "Ingredient Name": "ixabepilone",
    "Form": "injectable",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e7992f6b-279b-46a7-b9c3-fea4e17718dc",
    "DrugBank": "http://www.drugbank.ca/drugs/DB04845"
  },
  {
    "RxNorm (RxCUI)": 72965,
    "Ingredient Name": "letrozole",
    "Form": "oral tablet",
    "Supplemental information": "FDA Pregnancy Category X",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=letrozole",
    "DrugBank": "http://www.drugbank.ca/drugs/DB01006"
  },
  {
    "RxNorm (RxCUI)": 42375,
    "Ingredient Name": "leuprolide",
    "Form": "injectable",
    "Supplemental information": "FDA Pregnancy Category X",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=leuprolide",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00007"
  },
  {
    "RxNorm (RxCUI)": 6466,
    "Ingredient Name": "lomustine",
    "Form": "oral capsule",
    "Supplemental information": "IARC Group 2A carcinogen; NTP***; FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=lomustine",
    "DrugBank": "http://www.drugbank.ca/drugs/DB01206"
  },
  {
    "RxNorm (RxCUI)": 6674,
    "Ingredient Name": "mechlorethamine",
    "Form": "injectable & topical",
    "Supplemental information": "NTP***; FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=mechlorethamine",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00888"
  },
  {
    "RxNorm (RxCUI)": 6703,
    "Ingredient Name": "megestrol",
    "Form": "oral tablet",
    "Supplemental information": "Nursing should be dis-continued if megestrol is required; women at risk of pregnancy should avoid exposure; FDA Pregnancy Category X",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=megestrol",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00351"
  },
  {
    "RxNorm (RxCUI)": 6718,
    "Ingredient Name": "melphalan",
    "Form": "oral tablet",
    "Supplemental information": "IARC Group 1 carcinogen;NTP**; FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=melphalan",
    "DrugBank": "http://www.drugbank.ca/drugs/DB01042"
  },
  {
    "RxNorm (RxCUI)": 103,
    "Ingredient Name": "mercaptopurine",
    "Form": "oral tablet",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=mercaptopurine",
    "DrugBank": "http://www.drugbank.ca/drugs/DB01033"
  },
  {
    "RxNorm (RxCUI)": 6851,
    "Ingredient Name": "methotrexate",
    "Form": "oral tablet & injectable",
    "Supplemental information": "FDA Pregnancy Category X",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=methotrexate",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00563"
  },
  {
    "RxNorm (RxCUI)": 632,
    "Ingredient Name": "mitomycin",
    "Form": "injectable & Ophthalmic",
    "Supplemental information": "IARC Group 2B; FDA Preg nancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=mitomycin",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00305"
  },
  {
    "RxNorm (RxCUI)": 7004,
    "Ingredient Name": "mitotane",
    "Form": "oral tablet",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e9fba7d4-a0ec-4bfa-9b5b-ec97a9710fd3",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00648"
  },
  {
    "RxNorm (RxCUI)": 7005,
    "Ingredient Name": "mitoxantrone",
    "Form": "injectable",
    "Supplemental information": "IARC Group 2B; FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=mitoxantrone",
    "DrugBank": "http://www.drugbank.ca/drugs/DB01204"
  },
  {
    "RxNorm (RxCUI)": 274771,
    "Ingredient Name": "nelarabine",
    "Form": "injectable",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=893c95d7-d9b6-4064-db97-91dd21ce7e40",
    "DrugBank": "http://www.drugbank.ca/drugs/DB01280"
  },
  {
    "RxNorm (RxCUI)": 662281,
    "Ingredient Name": "nilotinib",
    "Form": "oral capsule",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6093952a-5248-45cb-ad17-33716a411146",
    "DrugBank": "http://www.drugbank.ca/drugs/DB04868"
  },
  {
    "RxNorm (RxCUI)": 1546446,
    "Ingredient Name": "omacetaxine",
    "Form": "????",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=83a504ef-cf92-467d-9ecf-d251194a3484",
    "DrugBank": "http://www.drugbank.ca/drugs/DB04865"
  },
  {
    "RxNorm (RxCUI)": 32592,
    "Ingredient Name": "oxaliplatin",
    "Form": "injectable",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=oxaliplatin",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00526"
  },
  {
    "RxNorm (RxCUI)": 56946,
    "Ingredient Name": "paclitaxel",
    "Form": "injectable",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=paclitaxel",
    "DrugBank": "http://www.drugbank.ca/drugs/DB01229"
  },
  {
    "RxNorm (RxCUI)": 1603350,
    "Ingredient Name": "panobinostat",
    "Form": "oral capsule",
    "Supplemental information": "Special warnings on contraception for females while taking and 1 month post-treatment;",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7774972a-eeaa-4b9a-9e56-3fc1b968e86a",
    "DrugBank": "http://www.drugbank.ca/drugs/DB06603"
  },
  {
    "RxNorm (RxCUI)": 714438,
    "Ingredient Name": "pazopanib",
    "Form": "oral tablet",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553",
    "DrugBank": "http://www.drugbank.ca/drugs/DB06589"
  },
  {
    "RxNorm (RxCUI)": 68446,
    "Ingredient Name": "pemetrexed",
    "Form": "injectable",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5a860f3-37ec-429c-ae04-9c88d7c55c08",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00642"
  },
  {
    "RxNorm (RxCUI)": 8011,
    "Ingredient Name": "pentostatin",
    "Form": "injectable",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=pentostatin",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00552"
  },
  {
    "RxNorm (RxCUI)": 1298944,
    "Ingredient Name": "pertuzumab",
    "Form": "injectable",
    "Supplemental information": "Black Box warning on embryo-fetal death and birth defects; FDA Preg-\tnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=17f85d17-ab71-4f5b-9fe3-0b8c822f69ff",
    "DrugBank": "http://www.drugbank.ca/drugs/DB06366"
  },
  {
    "RxNorm (RxCUI)": 8347,
    "Ingredient Name": "pipobroman",
    "Form": "????",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00236"
  },
  {
    "RxNorm (RxCUI)": 1369713,
    "Ingredient Name": "pomalidomide",
    "Form": "oral capsule",
    "Supplemental information": "Females of reproductive potential must use two forms of contraception or continuously abstain from heterosexual sex during and for 4 weeks after        stopping treatment; FDA Pregnancy Category X",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2b25ef01-5c9e-11e1-b86c-0800200c9a66",
    "DrugBank": "http://www.drugbank.ca/drugs/DB08910"
  },
  {
    "RxNorm (RxCUI)": 1364347,
    "Ingredient Name": "ponatinib",
    "Form": "oral tablet",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=807f988e-117b-4497-934d-73aa78baac71",
    "DrugBank": "http://www.drugbank.ca/drugs/DB08901"
  },
  {
    "RxNorm (RxCUI)": 662019,
    "Ingredient Name": "pralatrexate",
    "Form": "injection",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5e4cf15b-bf7b-4b83-863e-e9ef27741a51",
    "DrugBank": "http://www.drugbank.ca/drugs/DB06813"
  },
  {
    "RxNorm (RxCUI)": 8702,
    "Ingredient Name": "procarbazine",
    "Form": "oral capsule",
    "Supplemental information": "IARC Group 2A carcinogen; NTP***; FDA Pregnancy\tCategory D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=procarbazine",
    "DrugBank": "http://www.drugbank.ca/drugs/DB01168"
  },
  {
    "RxNorm (RxCUI)": 1312397,
    "Ingredient Name": "regorafenib",
    "Form": "oral tablet",
    "Supplemental information": "Black Box warning onsevere and sometimes fatal hepatotoxicity; total loss of pregnancy at doses lower than recommended human dose; FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=824f19c9-0546-4a8a-8d8f-c4055c04f7c7",
    "DrugBank": "http://www.drugbank.ca/drugs/DB08896"
  },
  {
    "RxNorm (RxCUI)": 877510,
    "Ingredient Name": "romidepsin",
    "Form": "injectable",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=romidepsin",
    "DrugBank": "http://www.drugbank.ca/drugs/DB06176"
  },
  {
    "RxNorm (RxCUI)": 495881,
    "Ingredient Name": "sorafenib",
    "Form": "oral tablet",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b50667e4-5ebc-4968-a646-d605058dbef0",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00398"
  },
  {
    "RxNorm (RxCUI)": 10114,
    "Ingredient Name": "streptozocin",
    "Form": "injectable",
    "Supplemental information": "IARC Group 2B; NTP***; FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=15d161ed-9e7b-4c92-ba45-0556d2423e67",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00428"
  },
  {
    "RxNorm (RxCUI)": 357977,
    "Ingredient Name": "sunitinib",
    "Form": "oral capsule",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c",
    "DrugBank": "http://www.drugbank.ca/drugs/DB01268"
  },
  {
    "RxNorm (RxCUI)": 10324,
    "Ingredient Name": "tamoxifen",
    "Form": "oral tablet",
    "Supplemental information": "IARC Group 1 carcinogen; NTP**; FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=tamoxifen",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00675"
  },
  {
    "RxNorm (RxCUI)": 37776,
    "Ingredient Name": "temozolomide",
    "Form": "oral capsule",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=temozolomide",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00853"
  },
  {
    "RxNorm (RxCUI)": 657797,
    "Ingredient Name": "temsirolimus",
    "Form": "injectable",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=95b7dc92-2180-42f1-8699-3c28f609e674",
    "DrugBank": "http://www.drugbank.ca/drugs/DB06287"
  },
  {
    "RxNorm (RxCUI)": 10362,
    "Ingredient Name": "teniposide",
    "Form": "injectable",
    "Supplemental information": "IARC Group 2A carcinogen; FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f19cf6d7-a1c8-42ec-844c-c798512139d9",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00444"
  },
  {
    "RxNorm (RxCUI)": 10485,
    "Ingredient Name": "thioguanine",
    "Form": "oral| tablet",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4490128b-e73f-4849-9d6e-e8591639d771",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00352"
  },
  {
    "RxNorm (RxCUI)": 10473,
    "Ingredient Name": "thiotepa",
    "Form": "oral| tablet & injectable",
    "Supplemental information": "IARC Group 1 carcinogen; NTP**; FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=thiotepa",
    "DrugBank": "http://www.drugbank.ca/drugs/DB04572"
  },
  {
    "RxNorm (RxCUI)": 57308,
    "Ingredient Name": "topotecan",
    "Form": "oral tablet & injectable",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=topotecan",
    "DrugBank": "http://www.drugbank.ca/drugs/DB01030"
  },
  {
    "RxNorm (RxCUI)": 38409,
    "Ingredient Name": "toremifene",
    "Form": "oral tablet",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=toremifene",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00539"
  },
  {
    "RxNorm (RxCUI)": 1425099,
    "Ingredient Name": "trametinib",
    "Form": "oral tablet",
    "Supplemental information": "Embryotoxic and abortifacient at doses less than rec-ommended human dose;FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aeaf0430-f8ad-4e72-9dbf-1954503c3410",
    "DrugBank": "http://www.drugbank.ca/drugs/DB08911"
  },
  {
    "RxNorm (RxCUI)": 1670310,
    "Ingredient Name": "trifluridine/tipiracil (combina-tion only)",
    "Form": "oral tablet",
    "Supplemental information": "Embryo-fetal lethality andembryo-fetal toxicity atdoses lower than or similarto exposures at the recom-mended human dose",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f5beed22-d71d-4c0d-8dca-2c7317d65d85",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00432; http://www.drugbank.ca/drugs/DB09343"
  },
  {
    "RxNorm (RxCUI)": 38782,
    "Ingredient Name": "triptorelin",
    "Form": "oral tablet & injectable",
    "Supplemental information": "FDA Pregnancy Category X",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=triptorelin",
    "DrugBank": "http://www.drugbank.ca/drugs/DB06825"
  },
  {
    "RxNorm (RxCUI)": 31435,
    "Ingredient Name": "valrubicin",
    "Form": "injectable",
    "Supplemental information": "FDA Pregnancy Category C",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e96f30a0-6662-11de-8f80-0002a5d5c51b",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00385"
  },
  {
    "RxNorm (RxCUI)": 1098413,
    "Ingredient Name": "vandetanib",
    "Form": "oral tablet",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=vandetanib",
    "DrugBank": "http://www.drugbank.ca/drugs/DB05294"
  },
  {
    "RxNorm (RxCUI)": 1147220,
    "Ingredient Name": "vemurafenib",
    "Form": "oral tablet",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=38eea320-7e0c-485a-bc30-98c3c45e2763",
    "DrugBank": "http://www.drugbank.ca/drugs/DB08881"
  },
  {
    "RxNorm (RxCUI)": 11198,
    "Ingredient Name": "vinblastine",
    "Form": "injectable",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f073b58e-56d6-4c8d-a2ce-b37719402d77",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00570"
  },
  {
    "RxNorm (RxCUI)": 11202,
    "Ingredient Name": "vincristine",
    "Form": "injectable",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=vincristine",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00541"
  },
  {
    "RxNorm (RxCUI)": 39541,
    "Ingredient Name": "vinorelbine",
    "Form": "injectable",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=vinorelbine",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00361"
  },
  {
    "RxNorm (RxCUI)": 1242987,
    "Ingredient Name": "vismodegib",
    "Form": "oral tablet",
    "Supplemental information": "Black Box warning onembryo-fetal death or severe birth defects; recommend effective contra-\tception for females during\ttherapy and for 7 months after treatment; present in semen; no sperm donation during and 3 months post-treatment; FDA Pregnancy\tCategory D",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=eb368bb6-80e3-4df9-8a85-91df0a2ada6a",
    "DrugBank": "http://www.drugbank.ca/drugs/DB08828"
  },
  {
    "RxNorm (RxCUI)": 194337,
    "Ingredient Name": "vorinostat",
    "Form": "oral tablet",
    "Supplemental information": "Adverse embryo-fetaleffects at less than the recommended human dose;FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cd86ee78-2781-468b-930c-3c4677bcc092",
    "DrugBank": "http://www.drugbank.ca/drugs/DB02546"
  },
  {
    "RxNorm (RxCUI)": 1304475,
    "Ingredient Name": "ziv-aflibercept",
    "Form": "injectable",
    "Supplemental information": "Embryotoxic and teratogenic in rabbits at expo-",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f6725df6-50ee-4b0a-b900-d02ba634395d",
    "DrugBank": "http://www.drugbank.ca/drugs/DB08885"
  },
  {
    "RxNorm (RxCUI)": 190521,
    "Ingredient Name": "abacavir",
    "Form": "oral tablet & injectable",
    "Supplemental information": "FDA Pregnancy Category C;malignant tumors observedin male and female mice andrats; genotoxic in in vivo mi-cronucleus test",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=abacavir",
    "DrugBank": "http://www.drugbank.ca/drugs/DB01048"
  },
  {
    "RxNorm (RxCUI)": 299635,
    "Ingredient Name": "alefacept",
    "Form": "injectable",
    "Supplemental information": "Increased frequency of malig-nancies observed in treatedpatients; FDA Pregnancy Category B",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/archives/index.cfm?query=alefacept&date=",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00092"
  },
  {
    "RxNorm (RxCUI)": 1043,
    "Ingredient Name": "apomorphine",
    "Form": "oral tablet & injectable",
    "Supplemental information": "FDA Pregnancy Category C; genotoxic in several in vitro",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=apomorphine",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00714"
  },
  {
    "RxNorm (RxCUI)": 1256,
    "Ingredient Name": "azathioprine",
    "Form": "oral tablet",
    "Supplemental information": "IARC Group 1 carcinogen%u2020;NTP**; FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=azathioprine",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00993"
  },
  {
    "RxNorm (RxCUI)": 2002,
    "Ingredient Name": "carbamazepine",
    "Form": "oral tablet & injectable",
    "Supplemental information": "Black Box warning for aplasticanemia; congenital malformations in offspring of mothers\twho took drug; rapid transpla-\tcental passage; FDA Pregnancy Category D*",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=carbamazepine",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00564"
  },
  {
    "RxNorm (RxCUI)": 2348,
    "Ingredient Name": "chloramphenicol",
    "Form": "oral tablet & injectable",
    "Supplemental information": "IARC Group 2A carcinogen;NTP***; FDA PregnancyCategory C",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=chloramphenicol",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00446"
  },
  {
    "RxNorm (RxCUI)": 83171,
    "Ingredient Name": "cidofovir",
    "Form": "injectable",
    "Supplemental information": "FDA Pregnancy Category C",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=cidofovir",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00369"
  },
  {
    "RxNorm (RxCUI)": 3008,
    "Ingredient Name": "cyclosporine",
    "Form": "oral tablet & injectable",
    "Supplemental information": "IARC Group 1 carcinogen;NTP**; FDA PregnancyCategory C",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=cyclosporine",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00091"
  },
  {
    "RxNorm (RxCUI)": 11645,
    "Ingredient Name": "deferiprone",
    "Form": "oral tablet",
    "Supplemental information": "Genotoxic in vitro and in vivo; FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=deferiprone",
    "DrugBank": "http://www.drugbank.ca/drugs/DB08826"
  },
  {
    "RxNorm (RxCUI)": 42736,
    "Ingredient Name": "dexrazoxane",
    "Form": "injectable",
    "Supplemental information": "FDA Pregnancy CategoryC; secondary malignancies observed in patients treated\tlong term with Razoxane (a\tracemic mixture containing\tdexrazoxane); genotoxic in\tvitro and in vivo; in laboratory studies| testicular atrophy observed at or below the human dose",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=dexrazoxane",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00380"
  },
  {
    "RxNorm (RxCUI)": 3390,
    "Ingredient Name": "diethylstilbestrol",
    "Form": "oral tablet",
    "Supplemental information": "IARC Group 1 carcinogen; NTP**; FDA Pregnancy Category X",
    "Personal Protective Equipment": "",
    "DailyMed": "",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00255"
  },
  {
    "RxNorm (RxCUI)": 11118,
    "Ingredient Name": "divalproex",
    "Form": "oral tablet & injectable",
    "Supplemental information": "Black Box warning for teratogenicity; FDA Pregnancy Category D; tumors seen in laboratory studies at doses below MRHD",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=divalproex",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00313"
  },
  {
    "RxNorm (RxCUI)": 306266,
    "Ingredient Name": "entecavir",
    "Form": "oral tablet",
    "Supplemental information": "FDA Pregnancy Category C",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=046e61c9-9298-4b2e-b76e-b26b81fecd20",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00442"
  },
  {
    "RxNorm (RxCUI)": 4083,
    "Ingredient Name": "estradiol",
    "Form": "oral and injectablet",
    "Supplemental information": "Black Box warning for malignant neoplasms; increased risk of endometrial cancer| breast cancer| and ovarian cancer; in\tlaboratory studies| increased frequency of carcinomas of the breast| uterus| cervix| vagina| testis| and liver; present\tin breast milk; FDA Pregnancy Category X",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=estradiol",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00783"
  },
  {
    "RxNorm (RxCUI)": 692987,
    "Ingredient Name": "estrogen/ progesterone combinations",
    "Form": "",
    "Supplemental information": "IARC Group 1 carcinogen; NTP**; FDA Pregnancy Cat-\tegory X",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=estradiol",
    "DrugBank": ""
  },
  {
    "RxNorm (RxCUI)": 4099,
    "Ingredient Name": "estrogens| conjugated",
    "Form": "oral tablet",
    "Supplemental information": "Black Box warning for endometrial cancer and cardiovascular risks; long-term use in\twomen and laboratory studies increases frequency of several\tcancers; NTP**; FDA Pregnancy Category X",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=estrogen",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00286"
  },
  {
    "RxNorm (RxCUI)": 214549,
    "Ingredient Name": "estrogens| esterified",
    "Form": "oral tablet",
    "Supplemental information": "Black Box warning for endometrial cancer and cardio-\tvascular risks; NTP**; FDA\tPregnancy Category X",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=estrogen",
    "DrugBank": "http://www.drugbank.ca/drugs/DB09381"
  },
  {
    "RxNorm (RxCUI)": 33747,
    "Ingredient Name": "estropipate",
    "Form": "oral tablet",
    "Supplemental information": "Black Box warning for endometrial carcinoma in post-menopausal women and\tuse during pregnancy; FDA Pregnancy Category X",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=estropipate",
    "DrugBank": "http://www.drugbank.ca/drugs/DB04574"
  },
  {
    "RxNorm (RxCUI)": 1012892,
    "Ingredient Name": "fingolimod",
    "Form": "oral tablet",
    "Supplemental information": "FDA Pregnancy Category C; in laboratory studies| increased malformations and embryo-fetal deaths at less than the recommended human\tdose; malignant lymphomas observed in male and female\tmice",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cc9e1c8c-0e2b-44e2-878b-27057f786be9",
    "DrugBank": "http://www.drugbank.ca/drugs/DB08868"
  },
  {
    "RxNorm (RxCUI)": 4494,
    "Ingredient Name": "fluoxymesterone",
    "Form": "oral tablet",
    "Supplemental information": "Tumors in mice and rats andpossibly humans; FDA Preg-nancy Category X",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=fluoxymesterone",
    "DrugBank": "http://www.drugbank.ca/drugs/DB01185"
  },
  {
    "RxNorm (RxCUI)": 72236,
    "Ingredient Name": "fosphenytoin",
    "Form": "injectable",
    "Supplemental information": "Metabolized to phenytoin;FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=fosphenytoin",
    "DrugBank": "http://www.drugbank.ca/drugs/DB01320"
  },
  {
    "RxNorm (RxCUI)": 4678,
    "Ingredient Name": "ganciclovir",
    "Form": "oral tablet & injectable",
    "Supplemental information": "FDA Pregnancy Category C",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=ganciclovir",
    "DrugBank": "http://www.drugbank.ca/drugs/DB01004"
  },
  {
    "RxNorm (RxCUI)": 27169,
    "Ingredient Name": "leflunomide",
    "Form": "oral tablet",
    "Supplemental information": "Teratogenic in laboratorystudies at 1/10 human dose(HD); marked postnatal survival at 1/100 HD; FDA Pregnancy Category X; severe liver injury reported in patients; carcinogenicity observed at doses below HD",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=leflunomide",
    "DrugBank": "http://www.drugbank.ca/drugs/DB01097"
  },
  {
    "RxNorm (RxCUI)": 342369,
    "Ingredient Name": "lenalidomide",
    "Form": "oral tablet",
    "Supplemental information": "Analog of thalidomide; FDABlack Box warnings for limb abnormalities; Pregnancy Category X; in laboratory studies| caused thalidomide-type limb\tdefects in monkey offspring",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5fa97bf5-28a2-48f1-8955-f56012d296be",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00480"
  },
  {
    "RxNorm (RxCUI)": 475968,
    "Ingredient Name": "liraglutide recombinant",
    "Form": "injectable",
    "Supplemental information": "FDA Pregnancy Category C; Black Box warning for thyroid C-cell tumors| with supporting evidence in laboratory studies; also in laboratory studies|\tteratogenic at or below the\tMRHD",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=liraglutide",
    "DrugBank": "http://www.drugbank.ca/drugs/DB06655"
  },
  {
    "RxNorm (RxCUI)": 1000112,
    "Ingredient Name": "medroxyprogesterone acetate",
    "Form": "oral tablet",
    "Supplemental information": "IARC Group 2B; FDA Pregnancy Category X",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=medroxyprogesterone",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00603"
  },
  {
    "RxNorm (RxCUI)": 6835,
    "Ingredient Name": "methimazole",
    "Form": "oral tablet",
    "Supplemental information": "Appears in human breast milk;FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=methimazole",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00763"
  },
  {
    "RxNorm (RxCUI)": 1367839,
    "Ingredient Name": "mipomersen",
    "Form": "injectable",
    "Supplemental information": "Black Box warning on hepa-totoxicity; FDA Pregnancy Category B",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=34de65be-f110-4000-a0f1-cb00ec98658f",
    "DrugBank": "http://www.drugbank.ca/drugs/DB05528"
  },
  {
    "RxNorm (RxCUI)": 68149,
    "Ingredient Name": "mycophenolate mofetil",
    "Form": "oral tablet & injectable",
    "Supplemental information": "Black Box warning for embryo fetal toxicity| malignancies| and serious infections; increased risk of first-trimester pregnancy loss and increased\trisk of congenital malformations; FDA Pregnancy Category D; Special warning: Tablets should not be crushed\tand capsules should not be\topened or crushed. Avoid inhalation or direct contact with\tskin or mucous membranes of the powder contained in\tcapsules and oral suspension (before or after constitution). If such contact occurs| wash thoroughly with soap and water; rinse eyes with plain\twater.",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=mycophenolate+mofetil",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00688"
  },
  {
    "RxNorm (RxCUI)": 7145,
    "Ingredient Name": "mycophenolic acid",
    "Form": "oral tablet",
    "Supplemental information": "Black Box warning for first trimester pregnancy loss and an increased risk of congenital malformations; FDA Pregnancy Category D; Black Box\twarning for lymphomas and other malignancies; genotoxic in vitro and in vivo",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=mycophenolic+acid",
    "DrugBank": "http://www.drugbank.ca/drugs/DB01024"
  },
  {
    "RxNorm (RxCUI)": 53654,
    "Ingredient Name": "nevirapine",
    "Form": "oral tablet",
    "Supplemental information": "FDA Pregnancy Category B; in laboratory studies| hepatocellular adenomas and carcinomas at doses lower than human dose",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=nevirapine",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00238"
  },
  {
    "RxNorm (RxCUI)": 1370971,
    "Ingredient Name": "ospemifene",
    "Form": "oral tablet",
    "Supplemental information": "Black Box warning on increased risk of endometrial cancer in certain populations;risk of adverse outcomes during pregnancy and labor; FDA Pregnancy Category X",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8462d6ab-e3cd-4efa-a360-75bf8f917287",
    "DrugBank": "http://www.drugbank.ca/drugs/DB04938"
  },
  {
    "RxNorm (RxCUI)": 32624,
    "Ingredient Name": "oxcarbazepine",
    "Form": "oral tablet",
    "Supplemental information": "Tumors observed in laboratory studies at 1/10 MRHD; FDA Pregnancy Category C",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=oxcarbazepine",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00776"
  },
  {
    "RxNorm (RxCUI)": 196319,
    "Ingredient Name": "palifermin",
    "Form": "injectable",
    "Supplemental information": "FDA Pregnancy Category C;potential for stimulation oftumor growth",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=426f6e64-2c20-4a61-6d65-7320426f6e64",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00039"
  },
  {
    "RxNorm (RxCUI)": 679314,
    "Ingredient Name": "paliperidone",
    "Form": "oral tablet & injectable",
    "Supplemental information": "Metabolite of risperidone; ex-creted in human breast milk;FDA Pregnancy Category C",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=paliperidone",
    "DrugBank": "http://www.drugbank.ca/drugs/DB01267"
  },
  {
    "RxNorm (RxCUI)": 8149,
    "Ingredient Name": "phenoxybenzamine",
    "Form": "oral tablet",
    "Supplemental information": "IARC Group 2B; FDAPregnancy Category C",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=phenoxybenzamine",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00925"
  },
  {
    "RxNorm (RxCUI)": 8183,
    "Ingredient Name": "phenytoin",
    "Form": "oral tablet & injectable",
    "Supplemental information": "IARC Group 2B; NTP***; FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=phenytoin",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00252"
  },
  {
    "RxNorm (RxCUI)": 8727,
    "Ingredient Name": "progesterone",
    "Form": "oral tablet",
    "Supplemental information": "IARC Group 2B; NTP***",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=progesterone",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00396"
  },
  {
    "RxNorm (RxCUI)": "????",
    "Ingredient Name": "progestins",
    "Form": "",
    "Supplemental information": "FDA Pregnancy Category X",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=PROGESTIN+%5BESTABLISHED+PHARMACOLOGIC+CLASS%5D",
    "DrugBank": ""
  },
  {
    "RxNorm (RxCUI)": 8794,
    "Ingredient Name": "propylthiouracil",
    "Form": "oral tablet",
    "Supplemental information": "IARC Group 2B; NTP***; FDAPregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=propylthiouracil",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00550"
  },
  {
    "RxNorm (RxCUI)": 72143,
    "Ingredient Name": "raloxifene",
    "Form": "oral tablet",
    "Supplemental information": "Abortion and developmental abnormalities seen at low doses in laboratory studies;\tevidence of tumors at low doses in laboratory studies; FDA Pregnancy Category X",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=raloxifene",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00481"
  },
  {
    "RxNorm (RxCUI)": 134748,
    "Ingredient Name": "rasagiline",
    "Form": "oral tablet",
    "Supplemental information": "FDA Pregnancy Category C",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=rasagiline",
    "DrugBank": "http://www.drugbank.ca/drugs/DB01367"
  },
  {
    "RxNorm (RxCUI)": 35636,
    "Ingredient Name": "risperidone",
    "Form": "oral tablet & injectable",
    "Supplemental information": "Evidence of tumors at low doses in laboratory studies;\tmay be prolactin-mediated; FDA Pregnancy Category C",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=risperidone",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00734"
  },
  {
    "RxNorm (RxCUI)": 35302,
    "Ingredient Name": "sirolimus",
    "Form": "oral tablet",
    "Supplemental information": "AKA rapamycin; increased risk of lymphomas and other malignancies; embryotoxic and\tfetotoxic at 0.2 human dose; FDA Pregnancy Category C",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=sirolimus",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00877"
  },
  {
    "RxNorm (RxCUI)": 9997,
    "Ingredient Name": "spironolactone",
    "Form": "oral tablet",
    "Supplemental information": "FDA Pregnancy Category C; Black Box warning for tumoro-\tgenicity in laboratory studies",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=spironolactone",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00421"
  },
  {
    "RxNorm (RxCUI)": 42316,
    "Ingredient Name": "tacrolimus",
    "Form": "oral tablet",
    "Supplemental information": "Increased risk of lymphomasand other malignancies; reproductive effects seen in laboratory studies below the MRHD; excreted in breast milk; FDA Pregnancy Category C",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=tacrolimus",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00864"
  },
  {
    "RxNorm (RxCUI)": 1310520,
    "Ingredient Name": "teriflunomide",
    "Form": "oral tablet",
    "Supplemental information": "Black Box warning on severehepatotoxicity and terato-genicity| including majorbirth defects; FDA Pregnancy Category X",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4650d12c-b9c8-4525-b07f-a2d773eca155",
    "DrugBank": "http://www.drugbank.ca/drugs/DB08880"
  },
  {
    "RxNorm (RxCUI)": 10432,
    "Ingredient Name": "thalidomide",
    "Form": "oral tablet",
    "Supplemental information": "FDA Pregnancy Category X",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=thalidomide",
    "DrugBank": "http://www.drugbank.ca/drugs/DB01041"
  },
  {
    "RxNorm (RxCUI)": 1357536,
    "Ingredient Name": "tofacitinib",
    "Form": "oral tablet",
    "Supplemental information": "Black Box warning for lympho-ma and other malignancies;FDA Pregnancy Category C",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=tofacitinib",
    "DrugBank": "http://www.drugbank.ca/drugs/DB08895"
  },
  {
    "RxNorm (RxCUI)": 10996,
    "Ingredient Name": "uracil mustard",
    "Form": "???",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00791"
  },
  {
    "RxNorm (RxCUI)": 275891,
    "Ingredient Name": "valganciclovir",
    "Form": "oral tablet",
    "Supplemental information": "FDA Pregnancy Category C",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=valganciclovir",
    "DrugBank": "http://www.drugbank.ca/drugs/DB01610"
  },
  {
    "RxNorm (RxCUI)": 11413,
    "Ingredient Name": "zidovudine",
    "Form": "oral tablet",
    "Supplemental information": "IARC Group 2B; FDAPregnancy Category C",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=zidovudine",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00495"
  },
  {
    "RxNorm (RxCUI)": 16818,
    "Ingredient Name": "acitretin",
    "Form": "oral pill",
    "Supplemental information": "Black Box warning on adverse reproductive effects; FDA Pregnancy Category X",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=acitretin",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00459"
  },
  {
    "RxNorm (RxCUI)": 81864,
    "Ingredient Name": "alitretinoin",
    "Form": "topical gel",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=alitretinoin",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00523"
  },
  {
    "RxNorm (RxCUI)": 358274,
    "Ingredient Name": "ambrisentan",
    "Form": "oral tablet",
    "Supplemental information": "Black Box warning on adverse reproductive effects; reduced sperm counts in patients; FDA Pregnancy Category X",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=725d4e73-6c83-477a-adc6-0ae4a133a844",
    "DrugBank": "http://www.drugbank.ca/drugs/DB06403"
  },
  {
    "RxNorm (RxCUI)": 75207,
    "Ingredient Name": "bosentan",
    "Form": "oral tablet",
    "Supplemental information": "Black Box warning on adverse reproductive effects; Pregnancy Category X",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=749e42fb-2fe0-45dd-9268-b43bb3f4081c",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00559"
  },
  {
    "RxNorm (RxCUI)": 47579,
    "Ingredient Name": "cabergoline",
    "Form": "oral tablet",
    "Supplemental information": "Inhibition of conception and embryo fetal effects at doses below recommended human dose;\tFDA Pregnancy Category B",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=cabergoline",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00248"
  },
  {
    "RxNorm (RxCUI)": 68147,
    "Ingredient Name": "cetrorelix",
    "Form": "injectable",
    "Supplemental information": "FDA Pregnancy Category X",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aca7768e-28a7-4027-b1d8-e66247665f79",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00050"
  },
  {
    "RxNorm (RxCUI)": 4986,
    "Ingredient Name": "choriogonadotropin",
    "Form": "injectable",
    "Supplemental information": "FDA Pregnancy Category X; may cause fetal harm when administered to a pregnant woman",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=choriogonadotropin",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00097"
  },
  {
    "RxNorm (RxCUI)": 2596,
    "Ingredient Name": "clomiphene*",
    "Form": "oral tablet",
    "Supplemental information": "FDA Pregnancy Category X",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=clomiphene",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00882"
  },
  {
    "RxNorm (RxCUI)": 2598,
    "Ingredient Name": "clonazepam",
    "Form": "oral tablet",
    "Supplemental information": "Increased risk of congenital abnormalities when taken in first trimester; FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=clonazepam",
    "DrugBank": "http://www.drugbank.ca/drugs/DB01068"
  },
  {
    "RxNorm (RxCUI)": 2683,
    "Ingredient Name": "colchicine",
    "Form": "oral tablet",
    "Supplemental information": "FDA Pregnancy Category C; published animal reproduction and development studies indicate it causes embryofetal\ttoxicity| teratogenicity| and altered postnatal development at exposures within or above the clinical therapeutic range",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=colchicine",
    "DrugBank": "http://www.drugbank.ca/drugs/DB01394"
  },
  {
    "RxNorm (RxCUI)": 3478,
    "Ingredient Name": "dinoprostone",
    "Form": "oral tablet & injectable",
    "Supplemental information": "Hazardous only for women in late pregnancy; FDA PregnancyCategory C",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=dinoprostone",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00917"
  },
  {
    "RxNorm (RxCUI)": 233698,
    "Ingredient Name": "dronedarone",
    "Form": "oral tablet",
    "Supplemental information": "Teratogenic in laboratory studies at  MRHD; FDA PregnancyCategory X",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=dronedarone",
    "DrugBank": "http://www.drugbank.ca/drugs/DB04855"
  },
  {
    "RxNorm (RxCUI)": 228790,
    "Ingredient Name": "dutasteride",
    "Form": "oral tablet",
    "Supplemental information": "Women warned not to handle; FDA Pregnancy Category X",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=dutasteride",
    "DrugBank": "http://www.drugbank.ca/drugs/DB01126"
  },
  {
    "RxNorm (RxCUI)": 1482502,
    "Ingredient Name": "eslicarbazepine",
    "Form": "oral tablet",
    "Supplemental information": "Fetal malformations| fetal growth retardation| embryo-lethality| and reduced body weights observed in animal studies; excreted in human breast milk; FDA Pregnancy Category C",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3d0c9554-eaeb-4694-8089-00133fcadce3",
    "DrugBank": "http://www.drugbank.ca/drugs/DB09119"
  },
  {
    "RxNorm (RxCUI)": "???",
    "Ingredient Name": "ergonovine/methylergonovine",
    "Form": "",
    "Supplemental information": "Use is contraindicated during pregnancy because of its utero-tonic effects; FDA PregnancyCategory C",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=ergonovine",
    "DrugBank": "http://www.drugbank.ca/drugs/DB01253; http://www.drugbank.ca/drugs/DB00353"
  },
  {
    "RxNorm (RxCUI)": 25025,
    "Ingredient Name": "finasteride",
    "Form": "oral tablet",
    "Supplemental information": "Women should not handle crushed or broken finasteride tablets when they are pregnant\tor may potentially be pregnant|\tdue to potential risk to a male\tfetus; FDA Pregnancy Category X",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=finasteride",
    "DrugBank": "http://www.drugbank.ca/drugs/DB01216"
  },
  {
    "RxNorm (RxCUI)": 4450,
    "Ingredient Name": "fluconazole",
    "Form": "oral tablet",
    "Supplemental information": "FDA Pregnancy Category C; case reports describe congenital anomalies in infants exposed in utero to maternal fluconazole\t(400-800 mg/ day) during most or all of the first trimester| similar to those seen in animal studies",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=fluconazole",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00196"
  },
  {
    "RxNorm (RxCUI)": 35825,
    "Ingredient Name": "ganirelix",
    "Form": "injectable",
    "Supplemental information": "FDA Pregnancy Category X",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=96118395-557e-4998-842d-424a59d574b6",
    "DrugBank": "http://www.drugbank.ca/drugs/DB06785"
  },
  {
    "RxNorm (RxCUI)": 4986,
    "Ingredient Name": "gonadotropin| chorionic",
    "Form": "injectable",
    "Supplemental information": "Defects of forelimbs and central nervous system and alterations in sex ratio have been reported in laboratory studies; FDA Pregnancy Category C",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f93b2baa-03ac-4650-b35a-20b818d712d6",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00097"
  },
  {
    "RxNorm (RxCUI)": 1148138,
    "Ingredient Name": "icatibant",
    "Form": "injectable",
    "Supplemental information": "FDA Pregnancy Category C; in laboratory studies| premature birth and abortion rates increased at a dose that was less than 1/40th the MRHD| and delayed parturition and fetal death occurred at 0.5 and 2-fold| respectively| the MRHD",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ed6657ca-ab68-477a-9968-e12dc928b540",
    "DrugBank": "http://www.drugbank.ca/drugs/DB06196"
  },
  {
    "RxNorm (RxCUI)": 1364479,
    "Ingredient Name": "lomitapide",
    "Form": "oral tablet",
    "Supplemental information": "FDA Pregnancy Category X",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e4c45bb5-15f4-437e-ab98-a649b3676d14",
    "DrugBank": "http://www.drugbank.ca/drugs/DB08827"
  },
  {
    "RxNorm (RxCUI)": 1442132,
    "Ingredient Name": "macitentan",
    "Form": "oral tablet",
    "Supplemental information": "Black Box warning for embryo-fetal toxicity; special warnings on contraception for females\twhile taking and 1 month post-treatment; FDA Pregnancy Category X",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1e484a50-55db-4b85-8c57-6cd1b0353abd",
    "DrugBank": "http://www.drugbank.ca/drugs/DB08932"
  },
  {
    "RxNorm (RxCUI)": "????",
    "Ingredient Name": "mentropins",
    "Form": "",
    "Supplemental information": "FDA Pregnancy Category X",
    "Personal Protective Equipment": "",
    "DailyMed": "",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00032"
  },
  {
    "RxNorm (RxCUI)": 6904,
    "Ingredient Name": "methyltestosterone",
    "Form": "oral tablet",
    "Supplemental information": "FDA Pregnancy Category X",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=methyltestosterone",
    "DrugBank": "http://www.drugbank.ca/drugs/DB06710"
  },
  {
    "RxNorm (RxCUI)": 6964,
    "Ingredient Name": "mifepristone",
    "Form": "oral tablet",
    "Supplemental information": "When given to pregnant women| results in terminationof pregnancy; FDA Pregnancy Category X",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=542f3fae-8bc8-4f00-9228-e4b66c9ad6a9",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00834"
  },
  {
    "RxNorm (RxCUI)": 42331,
    "Ingredient Name": "misoprostol",
    "Form": "oral tablet",
    "Supplemental information": "FDA Pregnancy Category X",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=misoprostol",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00929"
  },
  {
    "RxNorm (RxCUI)": 28656,
    "Ingredient Name": "nafarelin",
    "Form": "inhalant",
    "Supplemental information": "Note: Given only as nasal spray; no potential for occupationalexposure; FDA Pregnancy Category X",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d0aa57cb-d2f4-46d7-af43-7c8b06aa81a6",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00666"
  },
  {
    "RxNorm (RxCUI)": 7824,
    "Ingredient Name": "oxytocin",
    "Form": "injectable",
    "Supplemental information": "Hazardous only for women in 3rd trimester; FDA Pregnancy Category C",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=oxytocin",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00107"
  },
  {
    "RxNorm (RxCUI)": 11473,
    "Ingredient Name": "pamidronate",
    "Form": "injectable",
    "Supplemental information": "Embryo-fetal toxicities at doses below the recommended hu-man dose; FDA PregnancyCategory D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=pamidronate",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00282"
  },
  {
    "RxNorm (RxCUI)": 32937,
    "Ingredient Name": "paroxetine",
    "Form": "oral tablet",
    "Supplemental information": "Increased risk of congenital abnormalities when taken infirst trimester; complicationsin pregnancy when taken inthird trimester; FDA PregnancyCategory D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=paroxetine",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00715"
  },
  {
    "RxNorm (RxCUI)": 1364105,
    "Ingredient Name": "pasireotide",
    "Form": "injectable",
    "Supplemental information": "Increased implantation loss and decreased viable fetuses| corpora lutea| and implantation\tsites at doses less than the hu-\tman recommended dose; FDA\tPregnancy Category C",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=pasireotide",
    "DrugBank": "http://www.drugbank.ca/drugs/DB06663"
  },
  {
    "RxNorm (RxCUI)": 132879,
    "Ingredient Name": "pentetate calcium trisodium",
    "Form": "injectable",
    "Supplemental information": "Severe teratogenic effects in laboratory studies in dogs; sup-plied in ampule| which can leadto occupational exposure; FDAPregnancy Category C",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6052c707-a8a3-43a7-80c2-7ad1ad9391a4",
    "DrugBank": ""
  },
  {
    "RxNorm (RxCUI)": 1248798,
    "Ingredient Name": "peginesatide",
    "Form": "injectable",
    "Supplemental information": "Adverse embryo-fetal effects| including reduced fetal weight| increased resorption| embryofetal lethality| and cleft palate| observed in doses below the\trecommended human dose;\tFDA Pregnancy Category C",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/archives/index.cfm?query=peginesatide&date=",
    "DrugBank": "http://www.drugbank.ca/drugs/DB08894"
  },
  {
    "RxNorm (RxCUI)": 733003,
    "Ingredient Name": "plerixafor",
    "Form": "injectable",
    "Supplemental information": "Teratogenic in laboratory studies; FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a56b1b78-0ae2-41b4-9c76-98ad9d439199",
    "DrugBank": "http://www.drugbank.ca/drugs/DB06809"
  },
  {
    "RxNorm (RxCUI)": 9344,
    "Ingredient Name": "ribavirin",
    "Form": "oral tablet",
    "Supplemental information": "Teratogenic and embryo-toxic effects in several laboratory studies; contraindicated in\twomen who are pregnant and in the male partners of women who are pregnant; FDA Pregnancy Category X",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=ribavirin",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00811"
  },
  {
    "RxNorm (RxCUI)": 1439816,
    "Ingredient Name": "riociguat",
    "Form": "oral tablet",
    "Supplemental information": "Exclude pregnancy before the start of treatment| monthlyduring treatment| and 1 monthafter stopping treatment; FDAPregnancy Category X",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7b57509a-3d5d-41d4-8fed-1471e26372a3",
    "DrugBank": "http://www.drugbank.ca/drugs/DB08931"
  },
  {
    "RxNorm (RxCUI)": 473837,
    "Ingredient Name": "telavancin",
    "Form": "injectable",
    "Supplemental information": "Black Box warning for potential risk to fetus and adverse repro-\tductive outcomes; reduced fetal\tweights and increased rates of\tdigit and limb malformations in\tthree species at clinical doses; FDA Pregnancy Category C",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=telavancin",
    "DrugBank": "http://www.drugbank.ca/drugs/DB06402"
  },
  {
    "RxNorm (RxCUI)": 10355,
    "Ingredient Name": "temazepam",
    "Form": "oral tablet",
    "Supplemental information": "Increased risk of congenital malformations associatedwith treatment during the firsttrimester of pregnancy; FDAPregnancy Category X",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=temazepam",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00231"
  },
  {
    "RxNorm (RxCUI)": 10379,
    "Ingredient Name": "testosterone",
    "Form": "oral tablet & injectable & topical gel",
    "Supplemental information": "Children should avoid contact with unwashed or unclothedapplication sites on skin; FDAPregnancy Category X",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=testosterone",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00624"
  },
  {
    "RxNorm (RxCUI)": 38404,
    "Ingredient Name": "topiramate",
    "Form": "oral tablet",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=topiramate",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00273"
  },
  {
    "RxNorm (RxCUI)": 10753,
    "Ingredient Name": "tretinoin",
    "Form": "oral tablet & topical gel",
    "Supplemental information": "Black Box warning for severe birth defects; Special FDA distri-bution system; FDA PregnancyCategory X",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=tretinoin",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00755"
  },
  {
    "RxNorm (RxCUI)": 1005921,
    "Ingredient Name": "ulipristal",
    "Form": "oral tablet",
    "Supplemental information": "FDA Pregnancy Category X",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6e3f9f23-1fd4-4e14-8fd8-4a67263df99c",
    "DrugBank": ""
  },
  {
    "RxNorm (RxCUI)": 11118,
    "Ingredient Name": "valproate/valproic acid",
    "Form": "oral tablet & injectable",
    "Supplemental information": "Black Box warning for teratogenicity; congenital malformations| including neural tube defects; teratogenic in multiple species; FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/search.cfm?startswith=valproate&x=0&y=0; http://dailymed.nlm.nih.gov/dailymed/search.cfm?startswith=valproic+acid&x=0&y=0",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00313"
  },
  {
    "RxNorm (RxCUI)": 14851,
    "Ingredient Name": "vigabatrin",
    "Form": "oral tablet",
    "Supplemental information": "Malformations seen in laboratory studies below the MRHD;FDA Pregnancy Category C",
    "Personal Protective Equipment": "",
    "DailyMed": "http://dailymed.nlm.nih.gov/dailymed/search.cfm?startswith=vigabatrin&x=0&y=0",
    "DrugBank": "http://www.drugbank.ca/drugs/DB01080"
  },
  {
    "RxNorm (RxCUI)": 121243,
    "Ingredient Name": "voriconazole",
    "Form": "oral tablet & injectable",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=voriconazole",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00582"
  },
  {
    "RxNorm (RxCUI)": 11289,
    "Ingredient Name": "warfarin",
    "Form": "oral tablet",
    "Supplemental information": "FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=warfarin",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00682"
  },
  {
    "RxNorm (RxCUI)": 115698,
    "Ingredient Name": "ziprasidone",
    "Form": "oral tablet",
    "Supplemental information": "Developmental toxicity| including possible teratogenic effects at doses similar to human thera-\tpeutic doses; an increase in the number of pups born dead and a decrease in postnatal survival\tat less than MRHD; FDA Pregnancy Category C*",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=ziprasidone",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00246"
  },
  {
    "RxNorm (RxCUI)": 77655,
    "Ingredient Name": "zoledronic acid",
    "Form": "injectable",
    "Supplemental information": "Number of stillbirths increased and survival of neonates de-creased in laboratory studiesat low doses; FDA Pregnancy Category D",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=zoledronic+acid",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00399"
  },
  {
    "RxNorm (RxCUI)": 39998,
    "Ingredient Name": "zonisamide",
    "Form": "oral tablet",
    "Supplemental information": "Teratogenic in multiple miscellaneous animal species; FDA",
    "Personal Protective Equipment": "",
    "DailyMed": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=zonisamide",
    "DrugBank": "http://www.drugbank.ca/drugs/DB00909"
  }
]